Atricure, Inc.
Clinical trials sponsored by Atricure, Inc., explained in plain language.
-
New hybrid ablation offers hope for Hard-to-Treat AFib patients
Disease control OngoingThis study looks at a procedure called hybrid convergent ablation for people with long-standing persistent atrial fibrillation (AFib) that hasn't improved with medication. The procedure uses heat energy to destroy heart tissue causing the irregular rhythm, combining a small chest…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Disease control
Last updated May 17, 2026 05:45 UTC
-
Heart pouch closure during surgery may slash stroke risk
Prevention OngoingThis study tests whether closing the left atrial appendage (a small pouch in the heart) during heart surgery can prevent strokes in people who have risk factors for atrial fibrillation and stroke. Over 6,500 adults are taking part. The main goal is to see if this procedure reduce…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Prevention
Last updated May 17, 2026 05:36 UTC
-
New hybrid heart procedure offers hope for debilitating fast heartbeat
Symptom relief OngoingThis study tests a new hybrid procedure that combines two types of ablation to treat inappropriate sinus tachycardia (IST), a condition causing a fast heart rate and poor quality of life. The procedure aims to reduce heart rate and improve symptoms in 142 patients who have not re…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC